A Frailty Scale Predicts Outcomes of Patients with Newly Diagnosed Multiple Myeloma Who Are Ineligible for Transplant Treated with Continuous Lenalidomide Plus Low-Dose Dexamethasone on the First Trial
暂无分享,去创建一个
M. Dimopoulos | M. Mohty | A. Belch | E. Zamagni | T. Facon | C. Rose | A. Palumbo | Wenming Chen | J. Fermand | C. Hulin | A. Ervin‐Haynes | Shien Guo | A. Tempescul | N. Meuleman | Kihyun Kim | P. Rodríguez-Otero | William E. P. Renwick | Michael Sturniolo